FOXO1 and metastatic neoplasm: Our model identified a more favorable subset of patients with metastatic disease: FOXO1 fusion‐negative patients with only one site of metastasis, similar to the clinical findings of Oberlin et al.3 In this more favorable subset, 48 of 66 patients were under 10 years at diagnosis.